Clinical trial
Phase 3 Clinical Trial to Determine if Progesterone Along With Standard Medical Care for Brain Injury is More Effective at Limiting the Amount of Damage Cause by a Traumatic Brain Injury Than Standard Medical Care Alone.
NCT00822900 is registered in ClinicalTrials.gov with David Wright as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase 3 Clinical Trial to Determine if Progesterone Along With Standard Medical Care for Brain Injury is More Effective at Limiting the Amount of Damage Cause by a Traumatic Brain Injury Than Standard Medical Care Alone.
- Lead sponsor
- David Wright
- Phase
- Phase 3
- Overall status
- Terminated
- Start date
- March 31, 2010
- Completion date
- July 31, 2014
- Enrollment
- 882 (actual)
- Sites
- 36
Conditions
As the registry lists them; a condition with its own page is linked.
traumatic brain injury